Eli Lilly & Co
LLY· NYSE
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 |
|---|---|---|---|---|
| Revenue | $5.76B | $5.38B | $5.12B | $5.81B |
| Net Income | $771.80M | $478.40M | $428.50M | $727.50M |
| EPS Diluted | $0.73 |
Eli Lilly & Co · CIK 59478 · Engraved from SEC EDGAR
| $0.45 |
| $0.40 |
| $0.67 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.